Viewing Study NCT01139320


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:28 AM
Study NCT ID: NCT01139320
Status: COMPLETED
Last Update Posted: 2016-05-18
First Post: 2010-06-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin
Sponsor: Children's Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: AAML10B3
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View